Benzinga | May 25, 2021 06:43AM EDT

Barclays Initiates Coverage On Edwards Lifesciences with Overweight Rating, Announces Price Target of $110

Barclays analyst Travis Steed initiates coverage on Edwards Lifesciences (NYSE:EW) with a Overweight rating and announces Price Target of $110.